Propanc Biopharma announces 1-for-10 reverse stock split
PPCB•Propanc Biopharma announced a 1-for-10 reverse stock split to restore compliance with Nasdaq’s $1.00 minimum bid price requirement. The brief lists conflicting effective dates: October 26, 2026, at market open, and October 19, 2026, before market open.
1. Reverse split details
Every 10 outstanding common shares will become one share, with fractional shares rounded up to the nearest whole share. The announcement gives two different effective dates: market open October 26, 2026, and before market open October 19, 2026.
